


WorthlessViews
PremiumStoneCo NASDAQ:STNE revenue rise is staggering. Position started at $8.76. Chart looks ready for a move up, but nothing is guaranteed. Price Targets into 2027: $10.00 $12.00 $14.00 $16.00 $30.00 (long-term view)
GE Healthcare Technology $NASDAQ:GEHC. An aging and unhealthy population will only create an increased need for healthcare imaging services. Add AI to the diagnostic mix, and imaging will be imperative for routine health maintenance and screening. With a P/E of 15x, debt-to equity of 1x, earnings forecast growth of 8.36% per year, and bullish analyst ratings, this...
Acadia Healthcare's NASDAQ:ACHC stock has fallen nearly -76% in a year, primarily due to weak 2024 results, missed revenue and EPS expectations, and a soft 2025 revenue guidance. Ongoing federal investigations into billing practices and lawsuits have further eroded investor confidence. However, it is currently trading at a price-to-earnings ratio of 7.42x and...
It definitely should get everyone's attention when a US Senator (David McCormick) is willing to dish out up to $600,000 in a Bitcoin ETF ( AMEX:BITB ): Feb. 27: Bought $50,000 to $100,000 Feb. 28: Bought $15,000 to $50,000 March 3: Bought $50,000 to $100,000 March 5: Bought $15,000 to $50,000 March 10: Bought $50,000 to $100,000 March 11: Bought $15,000...
Dollar Tree NASDAQ:DLTR has taken a massive hit to its stock price as low-income spenders are cutting back (recession red flag, anyone?). It recently touched my selected "crash" simple moving average area (white lines on the chart) and may take many years before true recovery occurs. However, the Director recently bought $150k+ in shares after this recent drop,...
Celanese Corp is another chemical company (like Dow Inc) crushed by tariffs and economic headwinds. It's dropped -78% in one year.... However, this is a very strong company with strong credit market interest and no immediate liquidity crisis. From a technical analysis perspective, this... like in 2008 and 2020... is the time to gather shares given it has reached...
Ishares 20+ Treasury Bond NASDAQ:TLT are particularly sensitive to interest rates: the price moves up when they are lowered and down when they rise. Locally, I'm witnessing banks lower their interest rates for CDs and shorten the duration for those with high-yielding returns. The general political rhetoric, especially due to the election cycle, is a push for the...
For the patient, one of the "safest" investments is in long-term treasury bonds (specifically NASDAQ:TLT ). For those who may not understand why, bond prices move inversely to yields. If interest rates drop (which the Federal Reserve has stated is going to happen this year), NASDAQ:TLT will rise. If interest rates rise (like what happened in early 2022), ...
The United Postal Service NYSE:UPS finally closed out the last remaining price gap on the daily chart (since 2020) and entered my "crash" simple moving average zone. With a P/E of 15x, earnings forecast growth of 8.12% per year, and a dividend over 6%, NYSE:UPS "may" be a good buy and hold through these tumultuous economic/trade war times. I wouldn't place a...
Baidu NASDAQ:BIDU - the Google of China. This one is being ignored by AI investors, and may be an opportunity. Maybe... nothing is certain (especially with the "risks" of Chinese investments). P/E = 9x Debt/Equity = 0.27x Price/Sales = 1.55x Price/Book = 0.80x Price/Cash flow = 7.59x Thus, at $82.50, NASDAQ:BIDU is in a personal buy zone. ...
NYSE:DOW Inc is a strong company with good fundamentals currently trading at a good value (it just may take time for the value to truly show). P/E = 18x Dividend Yield = 7.74% Price/Cahs Flow = 6.9x Debt/Equity = 0.94x Price/Book = 1.14x Insiders buying and awarded options Thus, at $27.59, NYSE:DOW is in a personal buy zone. Targets: ...
Medical Properties Trust NYSE:MPW is a beaten down medical facility REIT currently in a price consolidation phase. The company's stock price is at a level not seen since the 2008-2009 financial crisis - but this doesn't mean it's a "steal" right now for investors. Here's why (from Wiki): "In 2022, The Wall Street Journal reported that Medical Properties Trust...
***Stay away if you are risk averse (small cap with 300-400k daily volume and could go to $0). VolitionRX AMEX:VNRX is a U.S.-based, multinational epigenetics company focused on developing blood tests for early disease detection, primarily targeting cancer and sepsis. Its Nu.Q blood tests are primarily for humans, focusing on early detection of diseases like...
NYSE:HCA Healthcare: P/E of 13x, earnings are forecast to grow 6.01% per year; earnings have grown 10.6% per year over the past 5 years, and trading at good value compared to peers and industry. From a technical analysis perspective, it dipped to my selected historical simple moving average area and may represent a buying opportunity to fill the daily price gap...
***New analysis / price targets given the recent 1/10 split:** The historical simple moving average (SMA) I've selected for Angi (formerly Angie's List Inc) NASDAQ:ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price...
The historical simple moving average (SMA) I've selected for Angi Inc NASDAQ:ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float,...
Across the US, there is a pent-up demand for housing (for the vast majority of locations). While the media likes to selectively report home sales dropping for certain regions, it is more due to mortgage rates and seasonality than demand. Mortgage rates are anticipated to come down over the next 1-2 years and home builders will step in to pick-up the lack of...
Like my predictions for AMEX:TNA , I believe midcap stocks will likely rise as interest rates are lowered over the next few years (probably a little too early given the looming economic situation). While it may be a bumpy ride and everything truly depends no announcement of an "official" economic recession (by which all stock expectations would change to the...